• Return to Headlines

Relatively High Forward P/E Ratio Detected in Shares of Pacira Pharmaceu in the Pharmaceuticals Industry (PCRX, COLL, ZTS, LLY, CTLT)

By Amy Schwartz

Below are the three companies in the Pharmaceuticals industry with the highest forward price to earnings (P/E) ratios. Forward P/E uses estimated earnings to compare relative value among companies in the same industry. Generally, the lower the forward P/E, the more undervalued a company is believed to be.

Pacira Pharmaceu ranks highest with a a forward P/E ratio of 40.26. Collegium Pharma is next with a a forward P/E ratio of 28.68. Zoetis Inc ranks third highest with a a forward P/E ratio of 28.19.

Eli Lilly & Co follows with a a forward P/E ratio of 22.22, and Catalent Inc rounds out the top five with a a forward P/E ratio of 21.99.

SmarTrend recommended that subscribers consider buying shares of Catalent Inc on January 16th, 2019 as our technology indicated a new Uptrend was in progress when shares hit $34.57. Since that recommendation, shares of Catalent Inc have risen 21.6%. We continue to monitor Catalent Inc for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: highest forward p/e ratio pacira pharmaceu collegium pharma zoetis inc eli lilly & co catalent inc

Ticker(s): PCRX COLL ZTS LLY CTLT